{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"4.100","floor":"5.000"},"ipodate":{"start":"2013-10-24 00:00:00","end":"2013-10-29 00:00:00"},"minimumcapital":"5040.40","subscribed":"17.40","marketcap":"54.67億","H_marketcap":"--","pe":"--","codesrate":"100.00","link":"https://www1.hkexnews.hk/listedco/listconews/sehk/2013/1024/ltn20131024008_c.htm","ipopricing":"4.100","resultdate":"2013-11-04 00:00:00","enddate":"2013-10-29 00:00:00","listeddate":"2013-11-05 00:00:00","issuenumber":"33333.40萬","issuenumberhK":"3333.40萬","issuenumberother":"30000.00萬","grayprice":"--","sponsors":"瑞銀證券香港有限公司","raisemoney":"143930.00萬","use":"1、約30%所得款項凈額或43180萬港幣，將用以繼續擴充我們的業務營運及提升我們的營銷、推廣及銷售能力； 2、約15%所得款項凈額或21590萬港幣，將用于升級現有及于湖北省建造新的物流及倉儲設施，以提升我們的倉儲能力及改善營運效率； 3、約5%所得款項凈額或7200萬港幣，將用于更換、改善及升級信息管理系統之硬件與軟件，以改善我們的管理及控制其推廣網絡及營運制造； 4、約25%所得款項凈額或35980萬港幣，將用于擴大產品組合； 5、約15%所得款項凈額或21590萬港幣，將用于海外供應商購入進口醫藥產品及醫療設備，以滿足不斷增長的需求； 6、約10%所得款項凈額或14390萬港幣，將用作我們的營運資金及其他一般企業用途。","shares":1000,"leadagent":"瑞士銀行香港分行,星展亞洲融資有限公司","bookrunners":"瑞士銀行香港分行,星展亞洲融資有限公司","coordinator":"瑞士銀行香港分行","firstDayOpen":"3.90","IsEiio":0,"Interestdays":6,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"瑞士銀行香港分行","code":"E01345","name":"中國先鋒醫藥","fullname":"中國先鋒醫藥控股有限公司"},"institutioninfo":{"principaloffice":"中國上海市普陀區武威路88弄15號","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"李新洲","secretary":"吳嘉雯","telephone":"(8621) 5049 8986","substantialshareholders":"李新洲及關連人士(70.81%)","principalactivities":"供應綜合性營銷、推廣及渠道管理服務予進口醫藥產品及醫療器械。 ","website":"http://www.pioneer-pharma.com"},"managerinfo":[],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":518}